EquityFlow
›
Investors
› Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture Fund
Corporate VC
At a glance
5 portfolio companies
5 rounds
2 led
$83.1M total
Portfolio
Company
Rounds
Invested
DiogenX
Biotech
1 round
$29.7M
Brainomix
Healthtech
1 round, 1 led
$21.8M
Aignostics
healthtech
1 round
$14.7M
Dopavision
Healthtech
1 round
$12M
Glox Therapeutics
Biotech
1 round, 1 led
$4.9M
Frequently co-invests with
Adbio Partners
1
Novartis
1
High-Tech Gründerfonds
1
Oxford University Innovation Fund
1
JDRF T1D Fund
1
Scottish Enterprise
1
Ababax Health
1
Roche Venture Fund
1
Omnes
1
Tencent
1
Wellington Partners
1
Parkwalk Advisors
1
Seventure Partners
1
IBB Ventures
1
Eli Lilly and Company
1
Carma Fund
1
Explore investors on EquityFlow →